Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study

BACKGROUND: Presence of disseminated tumor cells (DTCs) in bone marrow (BM) after completion of systemic adjuvant treatment predicts reduced survival in breast cancer. The present study explores the use of DTCs to identify adjuvant insufficiently treated patients to be offered secondary adjuvant tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Synnestvedt, Marit, Borgen, Elin, Wist, Erik, Wiedswang, Gro, Weyde, Kjetil, Risberg, Terje, Kersten, Christian, Mjaaland, Ingvil, Vindi, Lise, Schirmer, Cecilie, Nesland, Jahn Martin, Naume, Bjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576235/
https://www.ncbi.nlm.nih.gov/pubmed/23259667
http://dx.doi.org/10.1186/1471-2407-12-616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576235/
https://www.ncbi.nlm.nih.gov/pubmed/23259667
http://dx.doi.org/10.1186/1471-2407-12-616

Ejemplares similares